Dysregulation of E2F family (E2F1, E2F3 and E2F4) expression activates or silences oncogenes or tumor suppressors at multiple levels of gene regulation and is involved in CRC progression (Kent and Leone, 2019; Xu et al., 2021). Here, E2F3 is linked to colorectal carcinoma.